Pharmaceutical spray formulation comprising a hypro fluor alkane amd an acylated cyclodextrin

Details for Australian Patent Application No. 2004294775 (hide)

Owner AstraZeneca AB

Inventors Rogueda, Philippe

Agent Freehills

Pub. Number AU-B-2004294775

PCT Pub. Number WO2005/053637

Priority 0303179-6 26.11.03 SE

Filing date 24 November 2004

Wipo publication date 16 June 2005

Acceptance publication date 20 December 2007

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/573 (2006.01)

A61K 31/724 (2006.01)

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

Event Publications

1 June 2006 PCT application entered the National Phase

  PCT publication WO2005/053637 Priority application(s): WO2005/053637

20 December 2007 Application Accepted

  Published as AU-B-2004294775

17 April 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004294776-Brewing and drinking receptable

2004294773-Neoprene bib with material face